000285407 001__ 285407
000285407 005__ 20240304143042.0
000285407 0247_ $$2doi$$a10.1159/000534109
000285407 0247_ $$2pmid$$apmid:37812925
000285407 0247_ $$2ISSN$$a0253-4398
000285407 0247_ $$2ISSN$$a0257-2753
000285407 0247_ $$2ISSN$$a1421-9845
000285407 0247_ $$2ISSN$$a1421-9875
000285407 0247_ $$2ISSN$$a2571-872X
000285407 037__ $$aDKFZ-2023-02363
000285407 041__ $$aEnglish
000285407 082__ $$a610
000285407 1001_ $$aXiao, Qiyun$$b0
000285407 245__ $$aOnset time and characteristics of post-procedural bleeding after endoscopic resection of colorectal lesions: a multicenter retrospective study.
000285407 260__ $$aBasel$$bKarger$$c2024
000285407 3367_ $$2DRIVER$$aarticle
000285407 3367_ $$2DataCite$$aOutput Types/Journal article
000285407 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1709559001_15776
000285407 3367_ $$2BibTeX$$aARTICLE
000285407 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285407 3367_ $$00$$2EndNote$$aJournal Article
000285407 500__ $$a2024;42(1):78-86
000285407 520__ $$aIntroduction Postprocedural bleeding is a major adverse event after endoscopic resection of colorectal lesions, but the optimal surveillance time after endoscopy is unclear. In this study, we determined onset time and characteristics of postprocedural bleeding events. Methods We retrospectively screened patients who underwent endoscopic resection of colorectal lesions at three German hospitals between 2010 and 2019 for postprocedural bleeding events using billing codes. Only patients who required re-endoscopy were included for analysis. For identified patients, we collected demographic data, clinical courses, characteristics of colorectal lesions and procedure-related variables. Factors associated with late-onset bleeding were determined by univariate and multivariate logistic regression analysis. Results From a total of 6820 patients with eligible billing codes, we identified 113 cases with postprocedural bleeding after endoscopic mucosal (61.9%) or snare resection (38.1%) that required re-endoscopy. The median size of the culprit lesion was 20 mm (interquartile range 14-30 mm). The median onset time of postprocedural bleeding was day 3 (interquartile range: 1-6.5), with 48.7% of events occurring within 48 hours. Multivariate logistic regression analysis demonstrates that continued intake of antiplatelet drugs (OR 3.98, 95% CI 0.89-10.12, p = 0.025) and flat morphology of the colorectal lesion (OR 2.98, 95% CI 1.08-8.01, p = 0.031) were associated with an increased risk for late postprocedural bleeding (> 48 h), whereas intraprocedural bleeding was associated with a decreased risk (OR 0.12, 95% CI 0.04-0.50, p = 0.001). Discussion/Conclusion Significant postprocedural bleeding can occur up to 18 days after endoscopic resection of colorectal lesions, but was predominantly observed within 48 hours. Continued intake of antiplatelet drugs and a flat morphology are associated with risk for late postprocedural bleeding.
000285407 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000285407 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000285407 7001_ $$aEckardt, Maximilian$$b1
000285407 7001_ $$aMohamed, Awsan$$b2
000285407 7001_ $$aErnst, Helmut$$b3
000285407 7001_ $$aBehrens, Alexander$$b4
000285407 7001_ $$aHomann, Nils$$b5
000285407 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b6$$udkfz
000285407 7001_ $$aKähler, Georg$$b7
000285407 7001_ $$aEbert, Matthias$$b8
000285407 7001_ $$aBelle, Sebastian$$b9
000285407 7001_ $$aZhan, Tianzuo$$b10
000285407 773__ $$0PERI:(DE-600)1482221-0$$a10.1159/000534109$$gp. 1 - 9$$n1$$p78-86$$tDigestive diseases$$v42$$x0253-4398$$y2024
000285407 909CO $$ooai:inrepo02.dkfz.de:285407$$pVDB
000285407 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000285407 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000285407 9141_ $$y2023
000285407 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2023-10-21$$wger
000285407 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bDIGEST DIS : 2022$$d2023-10-21
000285407 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000285407 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000285407 980__ $$ajournal
000285407 980__ $$aVDB
000285407 980__ $$aI:(DE-He78)C060-20160331
000285407 980__ $$aUNRESTRICTED